SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-153369
Filing Date
2021-05-06
Accepted
2021-05-06 16:37:51
Documents
3
Effectiveness Date
2021-05-06

Document Format Files

Seq Description Document Type Size
1 S-8 d389571ds8.htm S-8 73850
2 EX-5.1 d389571dex51.htm EX-5.1 4483
3 EX-23.1 d389571dex231.htm EX-23.1 1964
  Complete submission text file 0001193125-21-153369.txt   81313
Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255835 | Film No.: 21898488
SIC: 2836 Biological Products, (No Diagnostic Substances)